Retractable syringes maker Unilife Corporation (UNIS) has clinched a two-year contract from Premier Purchasing Partners LP (the purchasing unit of Premier Inc) to supply its Unitract 1mL (milliliter) safety syringes.
Premier Purchasing Partners LP is one of the largest health care group purchasing organizations (GPOs) in the U.S. Premier Inc. is the biggest healthcare alliance in the U.S. helping to improve performance and providing group contracting to over 2,500 hospitals and more than 76,000 health care sites across the nation.
The Unitract line of insulin and tuberculin syringes boasts an automatic and fully- integrated safety feature aimed at preventing healthcare workers and patients from needle-stick injuries while injecting a drug supplied in a vial or ampule.
The Unitract range of 1mL syringes may be considered unique in the sense that they allow care givers to control the speed of automatic needle retraction. Unilife is producing the Unitract 1mL syringes at its manufacturing plant in Pennsylvania.
Unilife develops and markets advanced drug delivery systems. It collaborates with biotech and pharmaceutical companies and explores new devices that could be used with their drugs. The company has developed a wide array of its own injectable drug delivery products, including retractable syringes.
Unilife markets its prefilled syringes to pharmaceutical manufacturers, suppliers of medical products to health care facilities and patients who self-administer prescription drugs. Its patented syringes provide integrated safety, which is designed to protect patients from needle-stick injuries.
Prefilled syringes act as the device of choice for the administration of injectable vaccines and drugs that are marketed by over 20 pharmaceutical companies. Unilife is of the opinion that the pharma market for prefilled syringes is the most rapidly growing, relatively uncongested and most lucrative segment of the global syringe industry. Unilife competes with Becton, Dickinson and Company (BDX) among others.
BECTON DICKINSO (BDX): Free Stock Analysis Report
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment